Nitric oxide inhibits IFNγ-induced increases in CIITA mRNA abundance and activation of CIITA dependent genesclass II MHC, Ii and H-2M

Inflammation

Volumn 24, Issue 5, 2000, Pages 431-445

  Kielar, Mariusz L ^a   Sicher, Stanley C ^a   Penfield, Jeffery G ^a   Jeyarajah, D Rohan ^a   Lu, Christopher Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; NITRIC OXIDE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; RAT; RNA TRANSCRIPTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON-GAMMA, RECOMBINANT; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C3H; NITRIC OXIDE; NITRIC OXIDE DONORS; NUCLEAR PROTEINS; PENICILLAMINE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE;

EID: 2142659972     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007012128392     Document Type: Article

References (52)

1. 1. SZABOLCS, M., S. RAVALLI, O. MINANOV, R. R. SCIACCA, R. E. MICHLER, and P. J. CANNON. 1998. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 65:804-812.
2. 2. MACMlCKlNG, J., Q. W. XIE, and C. NATHAN. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
3. 3. IOANNIDIS, I., A. HELLINGER, C. DEHMLOW, U. RAUEN, J. ERHARD, F. W. EIGLER, and H. DEGROOT. 1995. Evidence for increased nitric oxide production after liver transplantation in humans. Transplantation 59:1293-1297.
4. 4. DEVLIN, J., R. M. PALMER, C. E. GONDE, J. O'GRADY, N. HEATON, K. C. TAN, J. F. MARTIN, S. MONCADA, and R. WILLIAMS. 1994. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation 58: 592-595.
5. 5. SMITH, S. D., M. A. WHEELER, R. ZHANG, E. D. WEISS, M. L. LORBER, W. C. SESSA, and R. M. WEISS. 1996. Nitric oxide synthase induction with renal transplant rejection or infection. Kidney Int. 50:2088-2093.
6. 6. BOGDAN, C. 1998. Commentary: The multiplex function of nitric oxide in (Auto) immunity. J. Exp. Med. 187:1361-1365.
7. 7. GABBAI, F. B., C. BOGGIANO, T. PETER, S. KHANG, C. ARCHER, D. P. GOLD, nd C. J. KELLY. 1997. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J. Immunol. 159:6266-6275.
8. 8. LANGREHR, J. M., R. A. HUFFMAN, J. R. JR. LANCASTER, and R. L. SIMMONS. 1993. Nitric oxide - a new endogenous immunomodulator. Transplantation 55:1205-1212.
9. 9. STOJANOVIC, T., H. J. GRONE, R. K. H. GIESELER, B. KLANKE, R. SCHLEMMINGER, D. TSIKAS, and E. F. GRONE. 1996. Enhanced renal allograft rejection by inhibitors of nitric oxide synthase: a nonimmunologic influence on alloreactivity. Lab. Invest. 74:496-512.
10. 10. SHEARS, L. L. I., N. KAWAHARADA, E. TZENG, T. R. BILLIAR, S. C. W ATKINS, I. KOVESDI, A. LIZONOVA, and S. M. PHAM. 1997. Inducible nitric oxide synthase suppresses the development of allograft atherosclerosis. J. Clin. Invest. 100:2035-2042.
11. 11. KOGLIN, J., T. GLYSING-JENSEN, J. S. MUDGETT, and M. E. RUSSELL. 1998. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: insights from NOS2-knockout mice. Am. J. Pathol. 153:1371-1376.
12. 12. KOGLIN, J., T. GLYSING-JENSEN, J. S. MUDGETT, and M. E. RUSSELL. 1998. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circul. 97:2059-2065.
13. 13. SlCHER, S. C., VAZQUEZ, M. A., and LU, C. Y. 1994. Inhibition of macrophage la expression by nitric oxide. J. Immunol. 153:1293-1300.
14. 14. SICHER, S. C., G. W. CHUNG, M. A. VAZQUEZ, and C. Y. Lu. 1995. Augmentation or inhibition of IFN-gamma-induced MHC class II expression by lipopolysaccharides: the roles of TNF-alpha and nitric oxide, and the importance of the sequence of signaling. J. Immunol. 155:5826-5834.
15. 15. HEUSCHLING, P. 1995. Nitric oxide modulates gamma-interferon-induced MHC class II antigen expression on rat astrocytes. J. Neuroimmunol. 35:63-69.
16. 16. HOLT, P. G., J. OLIVER, N. BILYK, C. NCMENAMIN, K. G. MCMENAMIN, and T. THEPEN. 1993. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177:397-407.
17. 17. AYALA, A., W. ERTEL, and I. H. CHAUDRY. 1996. Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 5:79-90.
18. 18. UNANUE, E. R. and P. M. ALLEN. 1987. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236:551-557.
19. 19. GREGORY, S. H., E. J. WING, R. A. HUFFMAN, and R. L. SIMMONS. 1993. Reactive nitrogen intermediates suppress the primary immunologic response to listeria. J. Immunol. 150:2901-2909.
20. 20. MACH, B., V. STEIMLE, E. MARTINEZ-SORIA, and W. REITH. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301-331.
21. 21. CRESSWELL, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505-507.
22. 22. CEMAN, S., and A. J. SANT. 1996. The function of invariant chain in class II-restricted antigen presentation. Semin. Immunol. 7: 373-387.
23. 23. KROPSHOFER, H., G. J. HAMMERLING, and A. B. BOGT. 1997. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today 18:77-82.
24. 24. SLOAN, V. S., P. CAMERON, G. PORTER, M. GAMMON, M. AMAYA, E. MELLINS, and D. M. ZALLER. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802-806.
25. 25. DENZIN, L. K., P. CRESSWELL. 1998. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82:155-165.
26. 26. SHERMAN, M. A., D. A. WEBER, and P. E. JENSEN. 1998. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197-205.
27. 27. VIVILLE, S., J. NEEFJES, V. LOTTEAU, A. DIERICH, M. LEMEUR, H. PLOEGH, C. BENOIST, and D. MATHIS. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635-648.
28. 29. BIKOFF, E. K., L. Y. HUANG, V. EPISKOPOU, J. MEERWIJK, R. N. GERMAIN, and E. J. ROBERTSON. 1998. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699-1712.
29. 30. MIYAZAKI, T., P. WOLF, S. TOURNE, C. WALZINGER, A. DIERICH, N. BAROIS, H. PLOEGH, C. BENOIST, and D. MATHIS. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531-541.
30. 31. FUNG-LEUNG, W. P., C. D. X. M. SURH, J. PANG, D. LETURCQ, P. A. PETERSON, S. R. WEBB, and L. KARLSSON. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278-1281.
31. 32. MARTIN, W. D., G. G. HICKS, H. I. LEVA, H. E. RULEY, and L. VAN KAER. 1998. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543-550.
32. 33. KARLSSON, L., A. PELERAUX, R. LINDSTEDT, M. LILJEDAHL, and P. A. PETERSON. 1994. Reconstitution of an operational MHC Class II compartment in nonantigen-presenting cells. Science 266:1569-1573.
33. 34. RASCHKE, W. C., S. BAIRD, P. RALPH, and I. NOKOINZ. 1978. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261.
34. 35. OI, V. T., P. P. JONES, J. W. GODING, and L. A. HERZENBERG. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and la antigens. In: Lymphocyte Hybridomas, Melchers, F., M. Potter, and N. Warner, Editors: Springer Verlag. New York. pp. 115-237.
35. 36. NATHAN, C. F. and J. B. HIBBS, JR. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
36. 37. STUEHR, D. J., S. S. GROSS, I. SAKUMA, R. LEVI, and C. F. NATHAN. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169:1011-1020.
37. 38. KHAIR-EL-DIN, T. A., S. C. SICHER, M. A. VAZQUEZ, W. J. WRIGHT, and C. Y. LU. 1995. Docosahexaenoic acid, a major constituent of fetal scrum and fish oil diets, inhibits IFN gamma induced la-expression by murine macrophages in vitro. J. Immunol. 154:1296-1306.
38. 39. DANIELSON, P. E., S. FORSS-PETTER, M. A. BROW. L. CALAVETTA, J. DOUGLASS, R. J. MILNER, and J. G. SUTCLIFFE. 1988. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261-267.
39. 40. CHANG, C. H., J. D. FONTES, M. PETERLIN, and R. A. FLAVELL. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367-1374.
40. 41. KHAIR-EL-DiN, T. A., S. C. SICHER, M. A. VAZQUEZ, G. W. CHUNG, K. L. STALLWORTH, K. KITAMURA, R. T. MILLER, and C. Y. LU. 1996. Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J. Exp. Med. 183:1241-1246.
41. 42. ESTESS, P., A. B. BOGOVICH, M. KOO, P. P. JONES, and H. O. MCDEVlTT. 1986. Sequence analysis and structure-function correlations of murine q. k, u, s and f haplotype I-A beta cDNA in pBSKII. Proc. Natl. Acad. Sci. U.S.A. 83:3594-3598.
42. 43. CHANG, C. H., S. GUERDER, S. C. HONG, W. VAN EWIJK, and R. A. FLAVELL. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC Class II expression. Immunity 4:167-178.
43. 44. GLIMCHER, L. H. and C. J. KARA. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13-49.
44. 45. NOACK, E. and M. FEELISCH. 1991. Molecular mechanisms of nitrovasodilator bioactivation. Basic Res. Cardiol. 86(suppl 2):37-50.
45. 46. CHANG, C. H. and R. A. FLAVELL. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765-767.
46. 47. CRESSWELL, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.
47. 48. TOURNE, S., T. MIYAZAKI, A. OXENIUS, L. KLEIN, T. FEHR, B. KYEWSKI, C. BENOIST, and D. MATHIS. 1997. Selection a broad repertoire of CD4+ T cells in H-2Ma 0/0 mice. Immunity 7:187-195.
48. 49. MARCINKIEWICZ, J., A. GRABOWSKA, and B. CHAIN. 1995. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25:947-951.
49. 50. TUCKER, S. D., M. R. SIVARAMAKRISHNAN, J. KLOSTERGAARD, and G. LOPEZ-BERESTEIN. 1991. Independence of the pattern of early cytokine release from autoregulation by nitric oxide. J. Leuko. Biol. 50:509.
50. 51. EIGLER, A., B. SINHA, and S. ENDRES. 1993. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem. Biophys. Res. Commun. 196:494.
51. 52. DUSTIN, L. B., SOBRMAN, R., C. M. SHEA, and C. Y. LU. 1990. Docosahexaenoic acid, a constituent of rodent fetal serum and fish oil diets, inhibits acquisition of macrophage tumoricidal function. J. Immunol. 144:4888-4897.
52. 53. BOSS, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107-113.